Showing results (2331-2340 of 6,740) with videos related to
Sort By:
Pageof 674
Oncotargets and Therapy|November 28, 2014
Post-nephrectomy foreign-body granuloma in the retroperitoneum mimicking lymph node metastasis of renal cell cancerJindan Luo, Yeqing Mao, Songliang Cai, et al.Oncotargets and Therapy|November 8, 2014
B7-H3 expression in breast cancer and upregulation of VEGF through gene silenceJing Sun, Yun-Di Guo, Xiao-Ning Li, et al.Oncotargets and Therapy|November 8, 2014
Gli3 silencing enhances cyclopamine suppressive effects on ovarian cancerHai-Yan Liu, Zheng DongOncotargets and Therapy|October 23, 2014
Cyclophosphamide-induced symptomatic hyponatremia, a rare but severe side effect: a case reportShereen Elazzazy, Asmaa Elhassan Mohamed, Amaal GuliedOncotargets and Therapy|October 23, 2014
Risk of treatment-related deaths with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis of 41 randomized controlled trialsShaodong Hong, Wenfeng Fang, Wenhua Liang, et al.Oncotargets and Therapy|October 25, 2014
Second-line docetaxel-based chemotherapy after failure of fluorouracil-based first-line treatment for advanced esophageal squamous cell carcinomaZhengbo Song, Yiping ZhangOncotargets and Therapy|October 21, 2014
Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancerMinya Yao, Yu Liu, Hailong Jin, et al.Oncotargets and Therapy|November 4, 2014
Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectivesGuang-Xia Chen, Shu Zhang, Xiao-Hua He, et al.Oncotargets and Therapy|November 5, 2014
Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphomaAndrew Bodiford, Megan Bodge, Mahsa S Talbott, et al.Oncotargets and Therapy|November 15, 2014
Antisense therapeutics in oncology: current statusAmmad Ahmad Farooqi, Zia Ur Rehman, Jordi MuntanePageof 674